Author:
Kucab Jill E,Lee Cathy,Chen Ching-Shih,Zhu Jiuxiang,Gilks C Blake,Cheang Maggie,Huntsman David,Yorida Erika,Emerman Joanne,Pollak Michael,Dunn Sandra E
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Nielsen T, Andrews H, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, et al: Expression of the insulin-like growth factor-1 receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: Potential for intervention with 17 allylamino 17-demethoxy geldanamycin. Cancer Res. 2004, 64: 286-291.
2. Sachdev D, Hartwell JS, Lee AV, Zhang X, Yee D: A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem. 2004, 279: 5017-5024. 10.1074/jbc.M305403200.
3. Kaleko M, Rutter WG, Miller DA: Overexpression of the human insulin-like growth factor-1 receptor promotes ligand dependent neoplastic transformation. Mol Cell Biol. 1990, 10: 464-473.
4. Dunn SE, Ehrlich M, Sharp NJH, Reiss K, Solomon G, Hawkins R, Baserga R, Barrett JC: A dominant negative mutant of the insulin-like growth factor-1 receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 1998, 58: 3353-3361.
5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of HER-2/neu oncogene. Science. 1987, 235: 177-182.
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献